摘要
目的:探究恩格列净(EMPA)调控人肾小球微血管内皮细胞(HRGEC)增殖、凋亡的作用机制。方法:30mmoL/L的葡萄糖诱导HRGEC建立高糖环境下的肾损伤细胞模型。恩格列净(250、500、1000nmoL/L)处理受损细胞。脂质体法将miR-NC组(转染miR-NC)、miR-497-3p组(转染miR-497-3p)、si-NC组(转染si-NC)、si-鱼糖基磷脂酰肌醇特异性磷脂酶D1(GPLD1)组(转染si-GPLD1)、EMPA+miR-497-3p+pcDNA组(共转染miR-497-3p和pcDNA)、EMPA+miR-497-3p+pcDNA-GPLD1组(共转染miR-497-3p和pcDNA-GPLD1)转染HRGEC细胞,并用30mmoL/L的葡萄糖或500nmoL/L恩格列净处理。细胞计数试剂盒(CCK-8)、流式细胞术检测细胞增殖率、凋亡率。蛋白免疫印迹(WB)实验检测细胞GPLD1、增殖细胞核抗原(PCNA)、细胞周期依赖性蛋白激酶抑制因子1A(P21)、半胱氨酸的天冬氨酸蛋白水解酶(Caspase)-3、Caspase-9蛋白表达。双荧光素酶报告实验、RNA结合蛋白免疫沉淀(RNA binding protein immunoprecipitation assay,RIP)实验检测细胞中miR-497-3p与GPLD1的结合力。结果:与NG组相比,HG组HRGEC细胞增殖率显著降低,凋亡率显著升高,miR-497-3p表达显著降低(P<0.05);与HG组相比,恩格列净(250、500、1000nmoL/L)组细胞增殖率显著升高,凋亡率显著降低,miR-497-3p表达显著升高(P<0.05),选出恩格列净的最适浓度500nmoL/L。miR-497-3p显著抑制野生型GPLD1细胞的荧光活性,促进Ago2-GPLD1的表达,负向调控GPLD1的蛋白表达。过表达miR-497-3p、敲减GPLD1具有相似的促进高糖诱导HRGEC细胞增殖,抑制凋亡的作用,并上调PCNA蛋白,下调P21、Caspase-3、Caspase-9蛋白。过表达GPLD1显著削弱恩格列净、过表达miR-497-3p对高糖诱导HRGEC细胞的增殖、凋亡调控作用。结论:恩格列净促进高糖诱导HRGEC细胞增殖,抑制凋亡,其机制与调控miR-497-3p/GPLD1信号通路相关。
Objective:To explore the mechanism of empagliflozin(EMPA)regulating the proliferation and apoptosis of human glomerular microvascular endothelial cells(HRGEC).Methods:HRGEC was induced by 30 mmoL/L glucose to establish the renal injury cell model in high glucose environment.The damaged cells were treated with englitazin(250,500,1000nmoL/L).HRGEC cells were transfected with miR-NC group(transfected miR-NC),miR-497-3p group(transfected miR-497-3p),si-NC group(transfected si-NC),si-fish glycosylphosphatidylinositol specific phospholipase D1(GPLD1)group(transfected si-GPLD1),EMPA+miR-497-3p+pcDNA group(co-transfected miR-497-3p and pcDNA),EMPA+miR-497-3p+pcDNA-GPLD1 group(co-transfected miR-497-3p and pcDNA-GPLD1),were all treated with 30mmoL/L glucose or 500 nmol/L empagliflozin.The cell proliferation rate and apoptosis rate were detected by cell counting kit(CCK-8)method and flow cytometry.The expressions of GPLD1,proliferating cell nuclear antigen(PCNA),cell cycle dependent protein kinase inhibitor 1a(p21),Caspase-3 and Caspase-9 were detected by western blotting(WB)assay.The binding ability of miR-497-3p to GPLD1 was detected by dual luciferase assay and RNA binding protein immunoprecipitation assay(RIP).Results:Compared with NG group,the proliferation rate significantly decreased in HG group,the apoptosis rate significantly increased,and the expression of miR-497-3p significantly decreased(P<0.05).Compared with HG group,the cell proliferation rate,apoptosis rate and the expression of miR-497-3p were significantly increased in empagliflozin(250,500 and 1000nmoL/L)group(P<0.05).The optimal concentration of empagliflozin was 500 nmol/L.MiR-497-3p significantly inhibited the fluorescence activity of wild-type GPLD1 cells,promoted the expression of Ago2-GPLD1,and negatively regulated the protein expression of GPLD1.Overexpression of miR-497-3p and knockdown of GPLD1 had similar effects on promoting the proliferation and inhibiting apoptosis,up-regulating PCNA protein and down-regulating p21,caspase-3 and caspase-9 protein of HRGEC cells induced by high glucose.Overexpression of GPLD1 significantly weakened the regulatory effects on the proliferation and apoptosis of empagliflozin and overexpression of miR-497-3p in HRGEC cells induced by high glucose.Conclusion:Empagliflozin could promote the proliferation and inhibit apoptosis of HRGEC cells induced by high glucose,and its mechanism is related to the regulation of miR-497-3p/GPLD1 signal pathway.
作者
高瑞超
李敏
金朋然
刘旋
冯雪
檀增桓
GAO Ruichao;LI Min;JIN Pengran(Handan Central Hospital, Hebei Handan 056000, China)
出处
《河北医学》
CAS
2022年第2期194-201,共8页
Hebei Medicine
基金
河北省卫生和计划生育委员会科研基金项目,(编号:20211203)。